1. Faure, G. et al. CRISPR–Cas in mobile genetic elements: counter-defence and beyond. Nat. Rev. Microbiol. 17, 513–525 (2019).
2. Wang, J. et al. Structural and Mechanistic Basis of PAM-Dependent Spacer Acquisition in CRISPR-Cas Systems. Cell 163, 840–853 (2015).
3. Xiao, Y., Ng, S., Hyun Nam, K. & Ke, A. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration. Nature 550, 137–141 (2017).
4. Wright, A. V. et al. Structures of the CRISPR genome integration complex. Science (80-. ). eaao0679 (2017). doi:10.1126/science.aao0679
5. Mohanraju, P. et al. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science (80-. ). 353, aad5147 (2016).
6. Deltcheva, E. et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602–607 (2011).
7. Sapranauskas, R. et al. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res. 39, 9275–9282 (2011).
8. Sternberg, S. H., Richter, H., Charpentier, E. & Qimron, U. Adaptation in CRISPR-Cas Systems. Mol. Cell 61, 797–808 (2016).
9. Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278 (2014).
10. Chylinski, K., Makarova, K. S., Charpentier, E. & Koonin, E. V. Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res. 42, 6091–6105 (2014).
11. Fonfara, I. et al. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res. 42, 2577–2590 (2014).
12. Esvelt, K. M. et al. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 10, 1116–1123 (2013).
13. Jinek, M. et al. A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science (80-. ). 337, 816–821 (2012).
14. Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. 109, E2579–E2586 (2012).
15. Deveau, H. et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190, 1390–1400 (2008).
16. Garneau, J. E. et al. The CRISPR/cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67–71 (2010).
17. Doudna, J. A. & Charpentier, E. The new frontier of genome engineering with CRISPR-Cas9. Science (80-. ). 346, 1258096–1258096 (2014).
18. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science (80-. ). (2013). doi:10.1126/science.1231143
19. Mali, P. et al. RNA-Guided Human Genome Engineering via Cas9. Science (80-. ). 339, 823–826 (2013).
20. Mojica, F. J. M., Díez-Villaseñor, C., García-Martínez, J. & Almendros, C. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155, 733–740 (2009).
21. Hou, Z. et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 110, 15644–15649 (2013).
22. Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186–191 (2015).
23. Müller, M. et al. Streptococcus thermophilus CRISPR-Cas9 systems enable specific editing of the human genome. Mol. Ther. 24, 636–644 (2016).
24. Hirano, H. et al. Structure and Engineering of Francisella novicida Cas9. Cell 164, 950–961 (2016).
25. Kim, E. et al. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat. Commun. 8, 1–12 (2017).
26. Harrington, L. B. et al. A thermostable Cas9 with increased lifetime in human plasma. Nat. Commun. 8, 1–8 (2017).
27. Jinek, M. et al. Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation. Science (80-. ). 343, 1247997–1247997 (2014).
28. Jiang, F., Zhou, K., Ma, L., Gressel, S. & Doudna, J. A. A Cas9-guide RNA complex preorganized for target DNA recognition. Science (80-. ). (2015). doi:10.1126/science.aab1452
29. Nishimasu, H. et al. Crystal Structure of Staphylococcus aureus Cas9. Cell 162, 1113–1126 (2015).
30. Anders, C., Niewoehner, O., Duerst, A. & Jinek, M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513, 569–573 (2014).
31. Jiang, F. et al. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage. Science (80-. ). 351, 867–871 (2016).
32. Zhu, X. et al. Cryo-EM structures reveal coordinated domain motions that govern DNA cleavage by Cas9. Nat. Struct. Mol. Biol. (2019). doi:10.1038/s41594-019-0258-2
33. Nishimasu, H. et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156, 935–949 (2014).
34. Rohs, R. et al. Origins of Specificity in Protein-DNA Recognition. Annu. Rev. Biochem. 79, 233– 269 (2010).
35. Luscombe, N. M. Amino acid-base interactions: a three-dimensional analysis of protein-DNA interactions at an atomic level. Nucleic Acids Res. 29, 2860–2874 (2001).
36. Li, X., Xiong, X. & Yi, C. Epitranscriptome sequencing technologies: Decoding RNA modifications. Nat. Methods 14, 23–31 (2016).
37. Zaccara, S., Ries, R. J. & Jaffrey, S. R. Reading, writing and erasing mRNA methylation. Nat. Rev. Mol. Cell Biol. 20, 608–624 (2019).
38. Meyer, K. D. & Jaffrey, S. R. Rethinking m 6 A Readers, Writers, and Erasers . Annu. Rev. Cell Dev. Biol. 33, 319–342 (2017).
39. Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201–206 (2012).
40. Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149, 1635–1646 (2012).
41. Linder, B. et al. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat. Methods 12, 767–772 (2015).
42. Liu, J. et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93–95 (2014).
43. Wang, X. et al. Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex. Nature 534, 575–578 (2016).
44. Jia, G. et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885–887 (2011).
45. Zheng, G. et al. ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility. Mol. Cell (2013). doi:10.1016/j.molcel.2012.10.015
46. Lewis, C. J. T., Pan, T. & Kalsotra, A. RNA modifications and structures cooperate to guide RNA-protein interactions. Nat. Rev. Mol. Cell Biol. 18, 202–210 (2017).
47. Xu, C. et al. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat. Chem. Biol. 10, 927–929 (2014).
48. Fustin, J. M. et al. XRNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell 155, 793 (2013).
49. Roundtree, I. A., Evans, M. E., Pan, T. & He, C. Dynamic RNA Modifications in Gene Expression Regulation. Cell 169, 1187–1200 (2017).
50. Engel, M. et al. The Role of m6A/m-RNA Methylation in Stress Response Regulation. Neuron 99, 389-403.e9 (2018).
51. Kleinstiver, B. P. et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523, 481–485 (2015).
52. Kleinstiver, B. P. et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat. Biotechnol. 33, 1293–1298 (2015).
53. Nishimasu, H. et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science (80-. ). 361, 1259–1262 (2018).
54. Sun, H., Zhang, M., Li, K., Bai, D. & Yi, C. Cap-specific, terminal N 6-methylation by a mammalian m6Am methyltransferase. Cell Res. 29, 80–82 (2019).
55. Boulias, K. et al. Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome. Mol. Cell 75, 631-643.e8 (2019).
56. Sendinc, E. et al. PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression. Mol. Cell 75, 620-630.e9 (2019).
57. Akichika, S. et al. Cap-specific terminal N 6 -methylation of RNA by an RNA polymerase II– associated methyltransferase. Science (80-. ). 363, (2019).
58. Kabsch, W. et al. XDS. Acta Crystallogr. Sect. D Biol. Crystallogr. (2010). doi:10.1107/S0907444909047337
59. Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. Sect. D Biol. Crystallogr. 69, 1204–1214 (2013).
60. Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. Sect. D Biol. Crystallogr. (2010). doi:10.1107/S0907444909042589
61. Emsley, P. & Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126–2132 (2004).
62. Adams, P. D. et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213–221 (2010).
63. Anders, C., Bargsten, K. & Jinek, M. Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9. Mol. Cell 61, 895–902 (2016).
64. Kleinstiver, B. P. et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490–495 (2016).
65. Kleinstiver, B. P. et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat. Biotechnol. 33, 1293–1298 (2015).
66. Makarova, K. S. et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13, 722–736 (2015).
67. Ma, E., Harrington, L. B., O’Connell, M. R., Zhou, K. & Doudna, J. A. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes. Mol. Cell 60, 398–407 (2015).
68. Chen, F. et al. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting. Nat. Commun. 8, 1–12 (2017).
69. Sun, W. et al. Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States. Mol. Cell 1–15 (2019). doi:10.1016/j.molcel.2019.09.025
70. Yamada, M. et al. Crystal structure of the minimal Cas9 from Campylobacter jejuni reveals the molecular diversity in the CRISPR-Cas9 systems. Mol. Cell 65, 1109-1121.e3 (2017).
71. Crooks, G., Hon, G., Chandonia, J. & Brenner, S. WebLogo: a sequence logo generator. Genome Res 14, 1188–1190 (2004).
72. Waterman, D. G. et al. The DIALS framework for integration software. CCP4 Newsl. protein Crystallogr. 49, 16–19 (2013).
73. Cowtan, K. The Buccaneer software for automated model building. 1. Tracing protein chains. Acta Crystallogr. Sect. D Biol. Crystallogr. 62, 1002–1011 (2006).
74. Ran, F. A., Hsu, P. D., Lin, C. & Gootenberg, J. S. Resource Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity. Cell 154, 1380–1389 (2013).
75. Lee, C. M., Cradick, T. J. & Bao, G. The neisseria meningitidis CRISPR-Cas9 system enables specific genome editing in mammalian cells. Mol. Ther. 24, 645–654 (2016).
76. Sternberg, S. H., Lafrance, B., Kaplan, M. & Doudna, J. A. Conformational control of DNA target cleavage by CRISPR-Cas9. Nature 527, 110–113 (2015).
77. Wei, C. M., Gershowitz, A. & Moss, B. N6, O2’-dimethyladenosine a novel methylated ribonucleoside next to the 5’ terminal of animal cell and virus mRNAs. Nature (1975). doi:10.1038/257251a0
78. Moteki, S. & Price, D. Functional coupling of capping and transcription of mRNA. Mol. Cell (2002). doi:10.1016/S1097-2765(02)00660-3
79. Bélanger, F., Stepinski, J., Darzynkiewicz, E. & Pelletier, J. Characterization of hMTr1, a human Cap1 2′-O-ribose methyltransferase. J. Biol. Chem. (2010). doi:10.1074/jbc.M110.155283
80. Keith, J. M., Ensinger, M. J. & Moss, B. HeLa cell RNA(2’-O-methyladenosine-N6-)- methyltransferase specific for the capped 5’-end of messenger RNA. J. Biol. Chem. 253, 5033– 5039 (1978).
81. Akichika, S. et al. Cap-specific terminal N 6 -methylation of RNA by an RNA polymerase II– associated methyltransferase. Science (80-. ). 363, 1–41 (2019).
82. Fan, H. et al. PCIF1, a novel human WW domain-containing protein, interacts with the phosphorylated RNA polymerase II. Biochem. Biophys. Res. Commun. 301, 378–385 (2003).
83. Iyer, L. M., Zhang, D. & Aravind, L. Adenine methylation in eukaryotes: Apprehending the complex evolutionary history and functional potential of an epigenetic modification. BioEssays 38, 27–40 (2016).
84. Mendel, M. et al. Methylation of Structured RNA by the m 6 A Writer METTL16 Is Essential for Mouse Embryonic Development. Mol. Cell 71, 986-1000.e11 (2018).
85. Sheldrick, G. M. A short history of SHELX. Acta Crystallographica Section A: Foundations of Crystallography (2008). doi:10.1107/S0108767307043930
86. Vonrhein, C., Blanc, E., Roversi, P. & Bricogne, G. Automated structure solution with autoSHARP. Methods Mol. Biol. (2007). doi:10.1385/1-59745-266-1:215
87. Terwilliger, T. C. et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. in Acta Crystallographica Section D: Biological Crystallography (2007). doi:10.1107/S090744490705024X
88. Goedecke, K., Pignot, M., Goody, R. S., Scheidig, A. J. & Weinhold, E. Structure of tile N6- adenine DNA methyltransferase M·TaqI in complex with DNA and a cofactor analog. Nat. Struct. Biol. 8, 121–125 (2001).
89. Mauer, J. et al. Reversible methylation of m6 Am in the 5′ cap controls mRNA stability. Nature 541, 371–375 (2017).
90. Wei, J. et al. Differential m 6 A, m 6 A m , and m 1 A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm. Mol. Cell 71, 973-985.e5 (2018).
91. Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M. & Joung, J. K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. (2014). doi:10.1038/nbt.2808
92. Chen, J. S. et al. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 550, 407–410 (2017).
93. Wang, H., La Russa, M. & Qi, L. S. CRISPR/Cas9 in Genome Editing and Beyond. Annu. Rev. Biochem. 85, 227–264 (2016).
94. Liu, X. M., Zhou, J., Mao, Y., Ji, Q. & Qian, S. B. Programmable RNA N 6-methyladenosine editing by CRISPR-Cas9 conjugates. Nat. Chem. Biol. 15, 865–871 (2019)